4.8 Review

The gamble between oncolytic virus therapy and IFN

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy

Limin Tian et al.

Summary: By introducing the murine OX40 ligand (OX40L) gene, the recombinant Newcastle disease virus (rNDV-mOX40L) can enhance anti-tumor immune response, inhibit tumor growth, and promote infiltration of tumor-specific T cells.

GENE THERAPY (2023)

Article Immunology

Oncolytic virus treatment differentially affects the CD56(dim) and CD56(bright) NK cell subsets in vivo and regulates a spectrum of human NK cell activity

Michelle Wantoch et al.

Summary: This study analyzed the mechanism by which reovirus modulates human NK cell activity. It was found that reovirus activates NK cells through the dependent manner of type I interferon, inducing STAT1 and STAT4 signaling, and producing different responses in CD56(dim) and CD56(bright) subsets. Moreover, reovirus treatment inhibits IL-15-induced NK cell proliferation and reduces AKT signaling. In vivo experiments also showed that CD56(bright) NK cells are transiently lost from the peripheral circulation at the peak of the IFN-I response, indicating their redistribution to secondary lymphoid tissue. The activation of both CD56(dim) and CD56(bright) NK cells by antiviral pathways induces a spectrum of activity that includes the NK cell-mediated killing of tumor cells and modulation of adaptive responses via the trafficking of IFN-gamma expressing CD56(bright) NK cells to lymph nodes.

IMMUNOLOGY (2022)

Article Medical Laboratory Technology

NK cell tumor therapy modulated by UV-inactivated oncolytic herpes simplex virus type 2 and checkpoint inhibitors

Yang Wang et al.

Summary: This study found that UV-oHSV2 can activate natural killer (NK) cells, enhancing the antitumor activity in vitro and in vivo. Further investigation revealed that this activation occurs through the Toll-like receptor 2 (TLR2)/NF-kappa B signaling pathway and leads to the release of IFN-gamma by NK cells. Additionally, the expression of the checkpoint molecules NKG2A and HLA-E was upregulated by UV-oHSV2 stimulation. Treatment with anti-NKG2A and anti-HLA-E antibodies further enhanced the antitumor effects of UV-oHSV2-activated NK cells.

TRANSLATIONAL RESEARCH (2022)

Article Oncology

Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma

Guidong Zhu et al.

Summary: Despite progressive combination treatments, the prognosis for glioblastoma (GBM) patients remains poor. Oncolytic viruses (OVs) have emerged as a promising therapeutic strategy for GBM by stimulating immune cells and enhancing tumor microenvironment (TME) through the release of cytokines like IFN-gamma. The study shows that oncolytic herpes simplex virus-1 (oHSV-1) enhances the antitumor efficacy of novel CD70-specific chimeric antigen receptor (CAR) T cells by promoting T cell infiltration and IFN-gamma release, supporting the use of CAR T therapy in GBM treatment strategies.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Oncology

IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity

Nader El-Sayes et al.

Summary: This study reveals the immunosuppressive role of oncolytic virus-induced IFN-I on antitumor immunity by promoting PD-L1 expression in tumor cells and leukocytes. Inhibition of IFN-I signaling through IFNAR blockade decreases PD-L1 expression and enhances tumor-specific T cell effector responses when combined with oncolytic virotherapy.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Article Oncology

Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients

Emma J. West et al.

Summary: By studying the immune response to oncolytic virus (OV) therapy, we have identified different immune responses and immune exhaustion profiles in patients. These profiles may help develop predictive biomarkers for more personalized cancer treatment.

CANCERS (2022)

Article Hematology

Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms

Maki Oku et al.

Summary: This study demonstrates that the third-generation oncolytic HSV-1 virus, T-01, has a direct oncolytic effect on human myeloma cells. The presence of peripheral blood mononuclear cells can enhance the anti-tumor effect, with pDCs and NK cells dominating the immune activation. Lenalidomide is likely to augment the anti-myeloma effect of HSV-1.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Virology

Herpesviruses and the Type III Interferon System

Yue Yin et al.

Summary: Type III interferons play a crucial role in antiviral protection of mucosal epithelial barriers, particularly against herpesviruses. Current knowledge on the interaction of herpesviruses with type III interferons is limited to studies on herpes simplex virus.

VIROLOGICA SINICA (2021)

Review Virology

Reovirus and the Host Integrated Stress Response: On the Frontlines of the Battle to Survive

Luke D. Bussiere et al.

Summary: This review discusses the integrated stress response (ISR) in cells and how MRV modulates it, exploring how interactions between MRV and ISR may enhance the effectiveness of cancer therapeutics.

VIRUSES-BASEL (2021)

Review Oncology

Measles Virus as an Oncolytic Immunotherapy

Christine E. Engeland et al.

Summary: Measles virus is being investigated as an innovative cancer treatment that selectively replicates in and kills cancer cells. Genetic engineering can enhance tumor specificity and therapeutic efficacy, while also activating antitumor immune responses. Clinical trials have shown promising results, and future research will focus on virus engineering and combination immunotherapies to improve clinical outcomes.

CANCERS (2021)

Article Biology

Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors

Amir Sasan Mozaffari Nejad et al.

Summary: Immunization with different titers of NDV lysate significantly reduced tumor volume, enhanced cytotoxic T lymphocyte production and lymphocyte proliferation rates, induced antitumor immune responses through increased IL-4 and IFN-gamma levels, and reduced IL-10 levels.

SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)

Review Cell Biology

Oncolytic Virotherapy: From Bench to Bedside

Ludi Yang et al.

Summary: Oncolytic viruses, either natural or genetically engineered, can replicate in tumor cells and inhibit tumor growth, making them an effective anticancer strategy. Their multifunctional characteristics suggest promising application prospects in cancer therapeutics.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Veterinary Sciences

Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines

Mariana Rodrigues Santos et al.

Summary: The oncolytic virotherapy using a lentogenic, non-lytic Newcastle disease virus expressing GFP showed promising antitumor activity against canine mammary carcinoma, especially in more malignant cancer cells. The downregulated genes in NDV-sensitive cells were enriched for antiviral mechanisms by interferon and immune system pathways, indicating the importance of these pathways in oncolysis by NDV.

VETERINARY AND COMPARATIVE ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-alpha/beta Receptor Signaling

Timo Oosenbrug et al.

Summary: Oncolytic viruses selectively infect and kill tumor cells while triggering immune responses that boost anticancer immunity. Successful oncolytic virotherapy relies on tightly controlled levels of IFN-I, which requires understanding when and how tumor cells induce IFN-I in response to specific viruses.

HUMAN GENE THERAPY (2021)

Article Chemistry, Medicinal

Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo

Xue Wang et al.

Summary: The study demonstrates that the engineered oncoVV expressing WCL induced higher levels of apoptosis and cytotoxicity in cancer cells, replicated faster, and showed increased antitumor activity in a mouse xenograft tumor model. This suggests that oncoVV-WCL could provide a new avenue for anticancer gene therapy.

MARINE DRUGS (2021)

Article Biochemistry & Molecular Biology

β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer

Jiali Hu et al.

Summary: The study demonstrates that propranolol pretreatment can enhance the propagation and therapeutic efficacy of T1012G virus in gastric cancer by regulating the STAT3-PKR signaling cascade, even in the presence of type I interferons.

CELL AND BIOSCIENCE (2021)

Article Cell Biology

C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells

Daishi Morimoto et al.

Summary: The relationship between cGAS/STING expression levels and susceptibility to C-REV in human pancreatic cancer cell lines is unclear. Despite some cells having a responsive STING pathway, they remain highly susceptible to C-REV infection.
Article Medicine, Research & Experimental

Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation

Lingjuan Chen et al.

Summary: Armed with IL-23 variants, oncolytic vaccinia viruses can enhance anti-tumor immune responses, transforming the tumor microenvironment to be more favorable for anti-tumor effects.

THERANOSTICS (2021)

Article Biotechnology & Applied Microbiology

Oncolytic activity of HF10 in head and neck squamous cell carcinomas

Shinichi Esaki et al.

CANCER GENE THERAPY (2020)

Article Biotechnology & Applied Microbiology

Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus

Sarah Aref et al.

MOLECULAR THERAPY (2020)

Review Biochemistry & Molecular Biology

The pros and cons of interferons for oncolytic virotherapy

Karen Geoffroy et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Review Immunology

Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing

Misbah El-Jesr et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

The Role of Structure in the Biology of Interferon Signaling

Mark R. Walter

FRONTIERS IN IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

The IFN-λ4 Conundrum: When a Good Interferon Goes Bad

Olusegun O. Onabajo et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)

Review Immunology

Fine-Tuning of Type I Interferon Response by STAT3

Ming-Hsun Tsai et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Biotechnology & Applied Microbiology

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Manish R. k Patel et al.

CANCER GENE THERAPY (2019)

Review Oncology

Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics

Zong Sheng Guo et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Review Rheumatology

Type I interferon in rheumatic diseases

Theresa L. Wampler Muskardin et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

Article Medicine, General & Internal

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Annick Desjardins et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Immunology

cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development

Kevin W. Ng et al.

TRENDS IN IMMUNOLOGY (2018)

Article Virology

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma

Janine Kimpel et al.

VIRUSES-BASEL (2018)

Review Virology

Defects in interferon pathways as potential biomarkers of sensitivity to oncolytic viruses

Olga V. Matveeva et al.

REVIEWS IN MEDICAL VIROLOGY (2018)

Article Oncology

APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

Amanda L. Huff et al.

MOLECULAR THERAPY-ONCOLYTICS (2018)

Review Biochemistry & Molecular Biology

Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches

Li Teng Khoo et al.

EMBO REPORTS (2018)

Review Cell Biology

Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection

Shi-fang Li et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Immunology

Type I Interferons and Natural Killer Cell Regulation in Cancer

Lena Mueller et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Cell Biology

Yin Yang 1 Dynamically Regulates Antiviral Innate Immune Responses During Viral Infection

Jie Zan et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Article Cell Biology

Roles of TRIM32 in Corneal Epithelial Cells After Infection with Herpes Simplex Virus

Hao Cui et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Oncology

Novel insights into mesothelioma biology and implications for therapy

Timothy A. Yap et al.

NATURE REVIEWS CANCER (2017)

Article Cell Biology

RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production

Sathish Kumar Maney et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)

Article Virology

Oncolytic herpes simplex virus interactions with the host immune system

Dipongkor Saha et al.

CURRENT OPINION IN VIROLOGY (2016)

Review Oncology

Antitumour actions of interferons: implications for cancer therapy

Belinda S. Parker et al.

NATURE REVIEWS CANCER (2016)

Article Medicine, General & Internal

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

H. Borghaei et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Brian A. Walker et al.

NATURE COMMUNICATIONS (2015)

Article Virology

Functions of the influenza A virus NS1 protein in antiviral defense

Robert M. Krug

CURRENT OPINION IN VIROLOGY (2015)

Review Immunology

Interferon-Stimulated Genes: A Complex Web of Host Defenses

William M. Schneider et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Review Biochemistry & Molecular Biology

Interferons: Success in anti-viral immunotherapy

Fan-ching Lin et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2014)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Review Immunology

Pattern recognition and signaling mechanisms of RIG-I and MDA5

Stephanie Reikine et al.

FRONTIERS IN IMMUNOLOGY (2014)

Review Immunology

Toll-like receptor signaling pathways

Takumi Kawasaki et al.

FRONTIERS IN IMMUNOLOGY (2014)

Review Immunology

Regulation of type I interferon responses

Lionel B. Ivashkiv et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Biotechnology & Applied Microbiology

Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors

D. Escobar-Zarate et al.

CANCER GENE THERAPY (2013)

Review Immunology

Interferon induction and function at the mucosal surface

Russell K. Durbin et al.

IMMUNOLOGICAL REVIEWS (2013)

Article Genetics & Heredity

An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers

Steven A. Roberts et al.

NATURE GENETICS (2013)

Article Medical Laboratory Technology

Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment

Didier Jean et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)

Review Cell Biology

The interferons and their receptors-distribution and regulation

Nicole A. de Weerd et al.

IMMUNOLOGY AND CELL BIOLOGY (2012)

Review Multidisciplinary Sciences

Innate or Adaptive Immunity? The Example of Natural Killer Cells

Eric Vivier et al.

SCIENCE (2011)

Article Immunology

Mouse CD8α+ DCs and human BDCA3+ DCs are major producers of IFN-λ in response to poly IC

Henning Lauterbach et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Editorial Material Biochemistry & Molecular Biology

Interferon-Lambda: A New Addition to an Old Family

Raymond P. Donnelly et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)

Review Biochemistry & Molecular Biology

The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress

Truyen Nguyen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

Impaired interferon signaling is a common immune defect in human cancer

Rebecca J. Critchley-Thorne et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Immunology

Expression and functional significance of SOCS-1 and SOCS-3 in Astrocytes

Hongwei Qin et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Multidisciplinary Sciences

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

Hiroki Ishikawa et al.

NATURE (2008)

Review Biochemistry & Molecular Biology

The interferons: 50 years after their discovery, there is much more to learn

Sidney Pestka

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Immunology

Type I IFN contributes to NK cell homeostasis, activation, and antitumor function

Jeremy B. Swann et al.

JOURNAL OF IMMUNOLOGY (2007)

Review Biochemistry & Molecular Biology

STAT activation and differential complex formation dictate selectivity of interferon responses

Joanna Wesoly et al.

ACTA BIOCHIMICA POLONICA (2007)

Article Biochemistry & Molecular Biology

Role of STAT3 in type I interferon responses - Negative regulation of STAT1-dependent inflammatory gene activation

Hao H. Ho et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biochemistry & Molecular Biology

Toll-like receptor signaling and IRF transcription factors

Kenya Honda et al.

IUBMB LIFE (2006)

Review Immunology

Type I interferons in host defense

Daniel B. Stetson et al.

IMMUNITY (2006)

Review Biochemistry & Molecular Biology

VSV-tumor selective replication and protein translation

GN Barber

ONCOGENE (2005)

Article Immunology

A critical function for type I interferons in cancer immunoediting

GP Dunn et al.

NATURE IMMUNOLOGY (2005)

Review Immunology

Mechanisms of type-I- and type-II-interferon-mediated signalling

LC Platanias

NATURE REVIEWS IMMUNOLOGY (2005)

Review Biotechnology & Applied Microbiology

Fighting cancer with vaccinia virus: Teaching new tricks to an old dog

YQ Shen et al.

MOLECULAR THERAPY (2005)

Review Cell Biology

Interferon-γ:: an overview of signals, mechanisms and functions

K Schroder et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2004)

Article Biotechnology & Applied Microbiology

Characterization of the type I interferon locus and identification of novel genes

MP Hardy et al.

GENOMICS (2004)

Review Immunology

Interferons, interferon-like cytokines, and their receptors

S Pestka et al.

IMMUNOLOGICAL REVIEWS (2004)

Review Immunology

Retroviral restriction by APOBEC proteins

RS Harris et al.

NATURE REVIEWS IMMUNOLOGY (2004)

Review Immunology

Interleukin-10 and related cytokines and receptors

S Pestka et al.

ANNUAL REVIEW OF IMMUNOLOGY (2004)

Article Biochemistry & Molecular Biology

Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

OI Kulaeva et al.

ONCOGENE (2003)

Article Multidisciplinary Sciences

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

P Loke et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Immunology

IL-28, IL-29 and their class II cytokine receptor IL-28R

P Sheppard et al.

NATURE IMMUNOLOGY (2003)

Article Biochemistry & Molecular Biology

Interferon-κ, a novel type I interferon expressed in human keratinocytes

DW LaFleur et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Immunology

Natural interferon α/β-producing cells link innate and adaptive immunity

N Kadowaki et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2000)